The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Methyl (4-(((4-(3-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-ureido)naphthalen-1-yl)oxy)ethyl)pyridin-2-yl)carbamate ID: ALA3781532
PubChem CID: 127031109
Max Phase: Preclinical
Molecular Formula: C34H36N6O4
Molecular Weight: 592.70
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)Nc1cc(CCOc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1
Standard InChI: InChI=1S/C34H36N6O4/c1-22-10-12-24(13-11-22)40-31(21-29(39-40)34(2,3)4)38-32(41)36-27-14-15-28(26-9-7-6-8-25(26)27)44-19-17-23-16-18-35-30(20-23)37-33(42)43-5/h6-16,18,20-21H,17,19H2,1-5H3,(H,35,37,42)(H2,36,38,41)
Standard InChI Key: ZNGVEWWGDVLDRD-UHFFFAOYSA-N
Molfile:
RDKit 2D
44 48 0 0 0 0 0 0 0 0999 V2000
-6.4694 10.5174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1704 9.7656 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.5091 9.9182 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.4688 12.0182 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.1711 8.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8739 7.5115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8775 6.0115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1785 5.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4757 6.0180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4720 7.5180 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5812 5.2552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5870 3.7544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2907 2.9981 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2907 -2.9981 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5870 -3.7544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6288 -3.1588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5812 -5.2552 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.0118 -7.4927 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.4782 -7.8082 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.2314 -6.5110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2305 -5.3938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8775 -6.0115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8881 -8.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4375 -8.1268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8122 -10.6485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3087 -9.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3969 -9.2071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2681 -11.0095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0203 -11.5128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7218 -6.3581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5073 12.6193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.4254 -7.3302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.2123 -5.2629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.9155 -6.2350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
1 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
5 10 2 0
11 12 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
14 23 2 0
18 23 1 0
24 25 1 0
25 26 2 0
25 27 1 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
28 32 1 0
33 34 1 0
33 36 2 0
34 37 2 0
35 37 1 0
35 38 2 0
36 38 1 0
35 39 1 0
28 33 1 0
30 40 1 0
27 32 1 0
17 24 1 0
13 14 1 0
12 13 1 0
7 11 1 0
2 5 1 0
4 41 1 0
40 42 1 0
40 43 1 0
40 44 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 592.70Molecular Weight (Monoisotopic): 592.2798AlogP: 7.47#Rotatable Bonds: 8Polar Surface Area: 119.40Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.31CX Basic pKa: 4.04CX LogP: 7.82CX LogD: 7.82Aromatic Rings: 5Heavy Atoms: 44QED Weighted: 0.17Np Likeness Score: -1.36
References 1. Onions ST, Ito K, Charron CE, Brown RJ, Colucci M, Frickel F, Hardy G, Joly K, King-Underwood J, Kizawa Y, Knowles I, Murray PJ, Novak A, Rani A, Rapeport G, Smith A, Strong P, Taddei DM, Williams JG.. (2016) Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma., 59 (5): [PMID:26800309 ] [10.1021/acs.jmedchem.5b01029 ]